What does a transferrin saturation of 16% indicate and how should it be evaluated and treated?

A transferrin saturation of 16% indicates iron deficiency and requires further evaluation with ferritin levels and assessment for underlying causes, followed by appropriate iron replacement therapy.

What This Value Means

A transferrin saturation (TSAT) of 16% is below the diagnostic threshold of 20% used to define iron deficiency in most clinical contexts 1. This low TSAT indicates insufficient iron availability for erythropoiesis and other metabolic processes, though interpretation must be contextualized with ferritin levels and clinical circumstances.

Key Diagnostic Thresholds by Clinical Context:

• General population/chronic heart failure: TSAT <20% defines iron deficiency 1
• Chronic kidney disease: TSAT ≤20% defines absolute iron deficiency (when combined with appropriate ferritin cutoffs) 1
• Hospitalized/inflammatory states: TSAT <16% has 61% sensitivity and 86% specificity for iron deficiency 2

Clinical Significance and Prognostic Implications

TSAT is a more reliable prognostic marker than ferritin alone, particularly in heart failure populations. Recent high-quality evidence demonstrates that low TSAT independently predicts mortality and adverse outcomes in heart failure with preserved ejection fraction (HFpEF), with every higher tertile of TSAT corresponding to a 40% reduction in heart failure events (HR 0.60, P=0.002) 3. Similarly, TSAT is associated with better metabolic and hemodynamic exercise responses, whereas ferritin shows no such correlations 3, 4.

Evaluation Algorithm

Step 1: Measure Ferritin Concurrently

The combination of TSAT and ferritin determines the type and severity of iron deficiency:

• Absolute iron deficiency: TSAT <20% + ferritin <100 μg/L (general population) 1
• Functional iron deficiency: TSAT <20% + ferritin 100-299 μg/L 1
• In CKD: Different ferritin thresholds apply (≤100 μg/L for predialysis/peritoneal dialysis; ≤200 μg/L for hemodialysis) 1

Step 2: Assess for Underlying Causes

Investigate for sources of blood loss and malabsorption, particularly:

• Gastrointestinal evaluation: Most patients with confirmed iron deficiency anemia warrant upper and lower GI endoscopy to exclude bleeding sources 1
• Menstrual history in premenopausal women
• Dietary assessment and malabsorptive conditions (celiac disease, autoimmune gastritis, post-bariatric surgery)
• Medication review: NSAIDs, anticoagulants, antiplatelet agents 1

Step 3: Identify Comorbidities That Modify Management

Chronic heart failure: 40-70% have iron deficiency defined as ferritin <100 μg/L and/or TSAT <20%. These patients should receive intravenous iron replacement as it provides prognostic benefit in meta-analyses, whereas oral iron shows no benefit and is poorly absorbed 1.

Chronic kidney disease: Management should involve nephrology consultation. Oral iron may be tried in predialysis patients, but intravenous iron is required if ineffective, not tolerated, or if dialysis has commenced 1.

Inflammatory bowel disease: TSAT may be helpful when ferritin is elevated due to inflammation (up to 100 μg/L may still reflect iron deficiency). Consider intravenous iron for intolerance to oral therapy or active disease 1.

Treatment Approach

First-Line Treatment (General Population)

Oral iron remains standard first-line therapy for most patients without specific contraindications 1. However, the route should be tailored to clinical context:

When to Use Intravenous Iron:

• Chronic heart failure (regardless of absolute vs. functional ID) 1
• Oral iron intolerance or ineffectiveness
• Malabsorption (IBD, post-bariatric surgery, celiac disease)
• CKD on dialysis 1
• Need for rapid repletion

Monitoring Response

Recheck complete blood count and iron parameters 4-8 weeks after treatment 5:

• Hemoglobin should increase 1-2 g/dL within 4-8 weeks
• Target ferritin ≥50 ng/mL in absence of inflammation 5
• Do not check iron parameters within 4 weeks of total dose infusion as circulating iron interferes with assays 5

Important Caveats

TSAT <20% has high sensitivity for diagnosing iron deficiency, but ferritin <100 ng/mL has low sensitivity (35-48%) 5. When TSAT and ferritin are discordant (low TSAT with elevated ferritin), this typically indicates functional iron deficiency in the setting of inflammation.

In children, interpretation differs: A TSAT <16% constitutes evidence of iron deficiency only in conjunction with anemia and low mean corpuscular volume, as normal children ages 0.5-12 years have lower TSAT values than adults 6, 7.

In hospitalized patients with chronic illness, the sensitivity and specificity of TSAT are reduced compared to healthier populations, so it cannot be relied upon as a sole screening test 2.